ArticleBlood cancer journal2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.
Sao-Chih Ni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it